 CRESSKILL, N.J. and JERUSALEM, May 19, 2021 GLOBE NEWSWIRE -- BrainsWay Ltd. NASDAQ TASE: BWAY BrainsWay or the Company, a global leader in the advanced noninvasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer MedTech, Tools Diagnostics Summit on May 26, 2021. The Company will also host one-on-one investor meetings at the conference. 